A Phase II, multicenter, double blind, double dummy, randomized, 2 arms parallel study to evaluate the efficacy, safety and pharmacokinetics of CHF6563 in babies with Neonatal Opioid Withdrawal Syndrome

Administered By

Awarded By

Contributors

Start/End

  • July 1, 2020 - June 30, 2021